Clinical Trial Update: Phase 2 Study of ABX-EGF (Panitumumab) in Japanese Subjects With M-colorectal Cancer [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 trial of panitumumab (ABX-EGF) in Japanese patients with metastatic colorectal cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)

Snippet

Sponsor: Amgen | Conditions: Metastatic Colorectal Cancer | Phase 2 | Status: COMPLETED